Your session is about to expire
← Back to Search
18F-fluoroestradiol for Endometriosis
Phase 2
Waitlist Available
Led By Jorge Oldan, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day of scan, up to 2 hours
Awards & highlights
Study Summary
This trial is testing whether a FES PET/MRI scan can detect endometriosis. 12 participants with clinically suspected endometriosis will have the scan before surgery to confirm the diagnosis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day of scan, up to 2 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day of scan, up to 2 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Sensitivity of FES PET/MRI for Evaluating Endometriosis (Percentage of Positive Scans)
Specificity of FES PET/MRI for Evaluating Endometriosis (Percentage of Negative Scans)
Secondary outcome measures
Correlation of the FES PET/MRI Specificity to Conventional MRI
Mean Standard Uptake Values (SUV-max) for 18F-fluoroestradiol PET / MRI
Side effects data
From 2022 Phase 2 trial • 8 Patients • NCT0438291117%
Fatigue
17%
Change in smell
17%
headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
18F-fluoroestradiol PET / MRI
Trial Design
1Treatment groups
Experimental Treatment
Group I: 18F-fluoroestradiol PET / MRIExperimental Treatment1 Intervention
All enrolled subjects will receive the tracer and then have a PET/MRI scan.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
18F-fluoroestradiol
2020
Completed Phase 2
~10
Find a Location
Who is running the clinical trial?
North Carolina Translational and Clinical Sciences InstituteOTHER
55 Previous Clinical Trials
4,279 Total Patients Enrolled
University of North Carolina, Chapel HillLead Sponsor
1,502 Previous Clinical Trials
4,186,734 Total Patients Enrolled
3 Trials studying Endometriosis
43 Patients Enrolled for Endometriosis
Jorge Oldan, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
3 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Endometriosis
24 Patients Enrolled for Endometriosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger